Market Highlights: C4 Therapeutics Inc (CCCC) Ends on a High Note at 6.17

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of C4 Therapeutics Inc (NASDAQ: CCCC) closed at $6.17 in the last session, up 0.16% from day before closing price of $6.16. In other words, the price has increased by $0.16 from its previous closing price. On the day, 1.12 million shares were traded. CCCC stock price reached its highest trading level at $6.35 during the session, while it also had its lowest trading level at $6.14.

Ratios:

We take a closer look at CCCC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.08 and its Current Ratio is at 5.08. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.25.

On December 13, 2023, Stifel Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $2 to $12.

Credit Suisse Upgraded its Underperform to Neutral on February 24, 2023, whereas the target price for the stock was revised from $12 to $10.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CCCC now has a Market Capitalization of 424531776 and an Enterprise Value of 283093536. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.19 while its Price-to-Book (P/B) ratio in mrq is 1.64. Its current Enterprise Value per Revenue stands at 13.639 whereas that against EBITDA is -2.064.

Stock Price History:

Over the past 52 weeks, CCCC has reached a high of $11.88, while it has fallen to a 52-week low of $1.06. The 50-Day Moving Average of the stock is -22.85%, while the 200-Day Moving Average is calculated to be 28.79%.

Shares Statistics:

According to the various share statistics, CCCC traded on average about 2.22M shares per day over the past 3-months and 1334080 shares per day over the past 10 days. A total of 60.47M shares are outstanding, with a floating share count of 57.88M. Insiders hold about 15.88% of the company’s shares, while institutions hold 72.63% stake in the company. Shares short for CCCC as of 1713139200 were 9562882 with a Short Ratio of 4.56, compared to 1710460800 on 5287035. Therefore, it implies a Short% of Shares Outstanding of 9562882 and a Short% of Float of 19.770001.

Most Popular